• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 13B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 13B; ANTI-REFLUX IMPLANT Back to Search Results
Model Number LXMC13
Device Problem Patient Device Interaction Problem (4001)
Patient Problem No Code Available (3191)
Event Date 07/30/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.The lot was not provided; therefore, the manufacturing record evaluation could not be performed.Additional information was requested, and the following was obtained: lot #? ¿ unknown.When using the linx sizing device what technique was used to determine the size? unknown.Did the patient have an autoimmune disease? - no.Is the patient currently taking steroids / immunization drugs? - unknown.Did the patient have any pre-existing dysphagia or other conditions (other than gerd)? - unknown.How severe was the dysphagia/odynophagia before intervention? - none.Were there any intra-operative complications during implant? - no.Was there any hiatal or crural repair done at the same time as the implant? - yes were there any other contributing factors that led to the removal of the device other than the reported dysphagia? ¿ no.What was the reason for removal of the linx device? ¿ patient felt like the device was ¿broken¿.Xrays showed it was still intact.Was the device found in the correct position/geometry at the time of removal? - yes.Was any additional imaging performed since device implant? does the device appear to be in a continuous annular state in these images? please share any additional images.- unknown.If information is obtained that was not available for the initial report, a follow-up report will be field as appropriate.
 
Event Description
It was reported that the patient had the lxmc13 implanted on (b)(6) 2019 for problems with gerd and a hiatal hernia repair.Since that time the patient felt like the device was broken and wanted it removed.X-rays indicated that the device was still in tact.The device was explanted on (b)(6) 2020.
 
Manufacturer Narrative
(b)(4).Date sent: 09/10/2020.Device analysis: overall review of the device function and dimensions show no anomalies from a device that has been reasonably changed as part of the explant procedure.Visual analysis was consistent with an explanted device, and link length and tensile force were found to meet the applicable specifications.Overall, no analysis conclusions relevant to the patient experience were found.The lot / batch was not provided; therefore, the manufacturing records could not be reviewed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 13B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
MDR Report Key10442424
MDR Text Key207332085
Report Number3008766073-2020-00126
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005332
UDI-Public00855106005332
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 07/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberLXMC13
Device Catalogue NumberLXMC13
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/27/2020
Initial Date Manufacturer Received 07/29/2020
Initial Date FDA Received08/24/2020
Supplement Dates Manufacturer Received08/27/2020
Supplement Dates FDA Received09/10/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-